Evidence map›Paper›PMID 29318045›Full record

ArticleJournal of drug delivery2017

Preparation, Characterization, and

Nidhi Sandal, Gaurav Mittal, Aseem Bhatnagar, Dharam Pal Pathak, Ajay Kumar Singh

Open access · hybridAbstract read
In one paragraph

Article in Journal of drug delivery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Prussian Blue: A Safe Pigment with Zeolitic-Like Activity.International journal of molecular sciences · 2021
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nidhi SandalDepartment of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Defence R&D Organisation, Brig. SK Mazumdar Road, Delhi 110 054, India.
Gaurav MittalDepartment of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Defence R&D Organisation, Brig. SK Mazumdar Road, Delhi 110 054, India.ORCID 0000-0001-6898-522X
Aseem BhatnagarDepartment of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Defence R&D Organisation, Brig. SK Mazumdar Road, Delhi 110 054, India.
Dharam Pal PathakDivision of Pharmaceutical Chemistry, DIPSAR, MB Road, Pushp Vihar, New Delhi 110 017, India.
Ajay Kumar SinghDepartment of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Defence R&D Organisation, Brig. SK Mazumdar Road, Delhi 110 054, India.
Institute of Nuclear Medicine & Allied Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrussian blue (PB, ferric hexacyanoferrate) is approved by US-FDA for internal decorporation of Cesium-137 (

aimSince PB is a costly drug, pH-dependent oral delivery system of PB was developed using calcium alginate matrix system.

methodsAlginate (Alg) beads containing PB were optimized by gelation of sodium alginate with calcium ions and effect of varying polymer concentration on encapsulation efficiency and release profile was investigated. Scanning electron microscopy (SEM) was carried out to study surface morphology. Adsorption efficacy of Alg-PB beads for

resultsEncapsulation efficiencies of Alg-PB beads with 0.5, 1.0, 1.5, and 2.0% polymer solution were 99.9, 91, 92, and 93%, respectively. SEM and particle size analysis revealed differences between formulations in their appearance and size distribution. No drug release was seen in acidic media (pH of 1-2) while complete release was observed at pH of 6.8. Dissolution data was fitted to various mathematical models and beads were found to follow Hixson-Crowell mechanism of release. The pH-dependent release of beads was confirmed

Identifiers

PMID29318045
PMCPMC5727830
OpenAlexW2770870904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.